Mark HELLMICH

Follow

Person

Galveston, TX, US

People

Patents Grantslast 30 patents

Information Patent Grant
Use of hydrogen sulfide synthesis inhibitors for cancer therapy
- Patent number 10,335,382
- Issue date Jul 2, 2019
- The Board of Regents of the University of Texas System
- Mark Hellmich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apigenin analogs, compositions, and methods related thereto
- Patent number 9,868,715
- Issue date Jan 16, 2018
- The Board of Regents of the University of Texas Systems
- Jia Zhou
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
USE OF HYDROGEN SULFIDE SYNTHESIS INHIBITORS FOR CANCER THERAPY
- Publication number 20190336462
- Publication date Nov 7, 2019
- The Board of Regents of the University of Texas System
- Mark HELLMICH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
APIGENIN ANALOGS, COMPOSITIONS, AND METHODS RELATED THERETO
- Publication number 20170204078
- Publication date Jul 20, 2017
- The Board of Regents of the University of Texas System
- Jia ZHOU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF HYDROGEN SULFIDE SYNTHESIS INHIBITORS FOR CANCER THERAPY
- Publication number 20160095831
- Publication date Apr 7, 2016
- The Board of Regents of the University of Texas System
- Mark HELLMICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE